Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Acebutolol products are in shortage in Canada (2 of 21 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A beta blocker used to lower blood pressure and treat certain heart rhythm problems.
Products affected
2 / 21
In shortage since
Mar 10, 2026
Reports on file
58
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TEVA-ACEBUTOLOL
400MG · TABLET · TEVA CANADA LIMITED
DIN 02204533 · since Apr 8, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-ACEBUTOLOL
100MG · TABLET · TEVA CANADA LIMITED
DIN 02204517 · since Mar 10, 2026, no end estimate · Disruption of the manufacture of the drug.
Resolved
APO-ACEBUTOLOL
200MG · TABLET · APOTEX INC
DIN 02147610 · ended Sep 5, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-ACEBUTOLOL
400MG · TABLET · APOTEX INC
DIN 02147629 · ended Sep 5, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-ACEBUTOLOL
100MG · TABLET · APOTEX INC
DIN 02147602 · ended Dec 14, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-ACEBUTOLOL
200MG · TABLET · APOTEX INC
DIN 02147610 · ended Dec 14, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-ACEBUTOLOL
400MG · TABLET · TEVA CANADA LIMITED
DIN 02204533 · ended Nov 1, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-ACEBUTOLOL
100MG · TABLET · TEVA CANADA LIMITED
DIN 02204517 · ended Oct 25, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-ACEBUTOLOL
100MG · TABLET · TEVA CANADA LIMITED
DIN 02204517 · ended Jul 5, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-ACEBUTOLOL
400MG · TABLET · TEVA CANADA LIMITED
DIN 02204533 · ended Jul 4, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-ACEBUTOLOL
200MG · TABLET · APOTEX INC
DIN 02147610 · ended Mar 15, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-ACEBUTOLOL
100MG · TABLET · APOTEX INC
DIN 02147602 · ended Sep 22, 2022 · Disruption of the manufacture of the drug.
Showing 12 of 58 reports. All reports are on file with Health Canada.
What's happening
Acebutolol is currently affected by 2 active shortage reports filed with Health Canada by TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Acebutolol is classified under “BETA BLOCKING AGENTS” (ATC C07AB).
Recent changes
No changes recorded yet.
Common questions
What is Acebutolol used for?
A beta blocker used to lower blood pressure and treat certain heart rhythm problems.
When will Acebutolol be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Acebutolol in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.